Identification of steroid isoxazole isomers marketed as designer supplement

Steroids

Volumn 74, Issue 3, 2009, Pages 322-328

  Parr, Maria K ^a   Gütschow, Michael ^b   Daniels, Jörg ^b   Opfermann, Georg ^a   Thevis, Mario ^a   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

17 Hydroxyandrostanoisoxazoles; Designer supplement; GC MS; NMR; X ray

Indexed keywords

17BETA HYDROXYANDROSTANO[2,3 D]ISOXAZOLE; 17BETA HYDROXYANDROSTANO[3,2 C]ISOXAZOLE; 5A ANDROSTANO[2,3 C]FURAZAN 17B TETRAHYDROPYRANOL ETHER; DESIGNER DRUG; ETHER; ISOXAZOLE; STEROID; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DRUG CAPSULE; DRUG IDENTIFICATION; DRUG LABELING; DRUG MARKETING; EXTRACTION; ISOMER; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; X RAY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLOGRAPHY, X-RAY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; ISOMERISM; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; STEROIDS;

EID: 61349130029     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.11.006     Document Type: Article

References (26)

1. Catlin D.H., Sekera M.H., Ahrens B.D., Starcevic B., Chang Y.C., and Hatton C.K. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 18 (2004) 1245-1249
2. Geyer H., Gülker A., Mareck U., Parr M.K., and Schänzer W. Some good news from the field of nutritional supplements. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent advances in doping analysis (12) (2004), Sport und Buch Strauß, Köln 91-97
3. Sekera M.H., Ahrens B.D., Chang Y.C., Starcevic B., Georgakopoulos C., and Catlin D.H. Another designer steroid: discovery, synthesis, and detection of 'madol' in urine. Rapid Commun Mass Spectrom 19 (2005) 781-784
4. Parr M.K., Opfermann G., and Schänzer W. Detection of new 17-alkylated anabolic steroids on wada 2006 list. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent advances in doping analysis (14) (2006), Sport und Buch Strauß, Köln 249-258
5. Rodchenkov G., Sobolevsky T., and Sizoi V. New designer anabolic steroids from internet. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent advances in doping analysis (14) (2006), Sport und Buch Strauß, Köln 141-150
6. Parr M., Geyer H., Opfermann G., and Schänzer W. Prescription drugs and new anabolic steroids in nutritional supplements. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent advances in doping analysis (12) (2004), Sport und Buch Strauß, Köln 71-80
7. Parr M., Opfermann G., and Schänzer W. Analytical properties of 4-hydroxysteroids and some esters. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent advances in doping analysis (12) (2004), Sport und Buch Strauß, Köln 129-139
8. Kazlauskas R. Miscellaneous projects in sports drug testing at the national measurement institute, Australia, 2005. In: Schänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent advances in doping analysis (14) (2006), Sport und Buch Strauß, Köln 129-140
9. Clinton R.O., Manson A.J., Stonner F.W., Christiansen R.G., Beyler A.L., Potts G.O., et al. Steroidal [2,3-d] isoxazoles. J Org Chem 26 (1961) 279
10. Manson A.J., Stonner F.W., Neumann H.C., Christiansen R.G., Clarke R.L., Ackerman J.H., et al. Steroidal heterocycles .7. Androstano [2,3-d] isoxazoles and related compounds. J Med Chem 6 (1963) 1-9
11. The Merck index (2001), Merck & Co., Inc., Whitehouse Station, NJ
12. ABDATA. List of pharmaceutical substances (2006), ABDATA Pharma-Daten-Service, Eschborn
13. World Anti-Doping Agency, The 2008 prohibited list, 2008, online at http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf, 17.04. 2008.
14. De Ruggieri P., Gandolfi C., and Chiaramonti D. Steroidi nota xii. Eterociclici steroidali. Alcuni derivati eterociclici in positione 2,3 dell'androstano e relativi composti. Gazz Chim Ital 92 (1962) 768-798
15. Nonius B.V. Collect data collection software (1999)
16. Otwinoski Z., and Minor W. Processing of X-ray diffraction data collected in oscillationmode, methods in enzymology. Volume 276. In: Carter C.W., and Sweet J.R.M. (Eds). Macromolecular crystallography, part A (1997), Academic Press 307-326
17. Sheldrick G.M. SHELXS-97. Acta Crystallogr, Sect A 46 (1990) 467
18. Sheldrick G.M. SHELXL-97 (1997), University of Göttingen
19. Alcock N.W. Crystallographic computing (1970) p. 271
20. Schänzer W., Opfermann G., and Donike M. Metabolism of stanozolol-identification and synthesis of urinary metabolites. J Steroid Biochem Mol Biol 36 (1990) 153-174
21. Marchetti E., and Donini P. Gazz Chim Ital 91 (1961) 1133-1141
22. Fahrenholtz K., Meyers K., and Kierstead R. Cycloprop 16alpha, 17alpha androstanes. J Med Chem 15 (1972) 1056-1060
23. Green T.W., and Wuts P.G.M. Protective groups in organic synthesis (1999), Wiley-Interscience, New York
24. German Federal Ministry of Health, Verordnung über verschreibungspflichtige Arzneimittel, Bundesgesetzblatt I, 2004, 3526-7.
25. Sobolevsky T, Virus E, Semenistaya E, Kachala V, Kachala I, Rodchenkov G. Orastan-A: Structural elucidation and detection in urine. Poster on 26th Cologne Workshop on Doping Analysis, February 2008.
26. Parr MK, Geyer H, Gütschow M, Haenelt N, Opfermann G, Piper T, et al. New steroids on the "supplement" market. Lecture on 26th Cologne Workshop on Doping Analysis, February 2008.